Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001026610 | SCV001189028 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-07-15 | criteria provided, single submitter | clinical testing | The c.75delC pathogenic mutation, located in coding exon 1 of the BRCA1 gene, results from a deletion of one nucleotide at nucleotide position 75, causing a translational frameshift with a predicted alternate stop codon (p.I26Sfs*5). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Fulgent Genetics, |
RCV005021335 | SCV005640305 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to, 4; Fanconi anemia, complementation group S | 2024-01-31 | criteria provided, single submitter | clinical testing |